93 related articles for article (PubMed ID: 332464)
1. Cyclacillin-induced potentiation of Escherichia coli immunogenicity in vivo and in vitro.
Friedman H; Warren GH
Chemotherapy; 1977; 23(5):324-36. PubMed ID: 332464
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria.
Friedman H; Warren GH
Proc Soc Exp Biol Med; 1976 Nov; 153(2):301-4. PubMed ID: 792892
[No Abstract] [Full Text] [Related]
3. Cyclacillin: in vitro activity against aerobic and anaerobic bacteria.
Thadepalli H; Roy I; Bach V
Chemotherapy; 1979; 25(5):303-7. PubMed ID: 383419
[TBL] [Abstract][Full Text] [Related]
4. Increased phagocytosis of Escherichia coli pretreated with subinhibitory concentrations of cyclacillin or ampicillin.
Friedman H; Warren GH
Proc Soc Exp Biol Med; 1982 Feb; 169(2):301-5. PubMed ID: 7038695
[No Abstract] [Full Text] [Related]
5. Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal.
Warren GH
Chemotherapy; 1976; 22(3-4):154-82. PubMed ID: 773605
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity in vitro of cyclacillin (author's transl).
Oliva B; Piccolomini R; Nicoletti M
Antibiotica; 1973; 11(3-4):105-10. PubMed ID: 4219567
[No Abstract] [Full Text] [Related]
7. Muramyl dipeptide-induced enhancement of phagocytosis of antibiotic pretreated Escherichia coli by macrophages.
Friedman H; Warren G
Proc Soc Exp Biol Med; 1984 Sep; 176(4):366-70. PubMed ID: 6379653
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclacillin and ampicillin on the gut flora of mice.
Schaedler RW; Warren GH
Chemotherapy; 1980; 26(4):289-96. PubMed ID: 7389426
[TBL] [Abstract][Full Text] [Related]
9. Blood levels and antibacterial activity of sera in patients treated with cyclacillin.
Yourassowsky E; Schoutens E; Vanderlinden MP; Butzler JP; Sternon J
Int J Clin Pharmacol; 1974 Mar; 9(2):120-4. PubMed ID: 4151243
[No Abstract] [Full Text] [Related]
10. [Microbiological study with cyclacillin].
Ravagnan G; Casalino M; Favalli C
Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1427-32. PubMed ID: 1024550
[No Abstract] [Full Text] [Related]
11. Pharmacological and in vitro evaluation of cyclacillin: assessment as potential single-dose therapy for treatment of Neisseria gonorrhoeae infection.
Wagner KF; Blair AD; Counts GW; Holmes KK
Antimicrob Agents Chemother; 1980 Jan; 17(1):89-91. PubMed ID: 6766294
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and antibacterial activity in vitro of some penicillins containing the phenylcyclohexanie residue].
Cantarelli G; Carissimi M; Ravenna F; Riva G
Farmaco Sci; 1975 Sep; 30(9):761-72. PubMed ID: 1157924
[TBL] [Abstract][Full Text] [Related]
13. Cyclacillin (cyclapen)--another new penicillin.
Med Lett Drugs Ther; 1980 Feb; 22(3):13-4. PubMed ID: 6986544
[No Abstract] [Full Text] [Related]
14. [Comparative experimental study of cyclacillin and ampicillin].
Rudzit EA; Iakovlev VP; Zinchenko TA; Kulikova DA; Lisitsa LI
Antibiotiki; 1979 May; 24(5):331-6. PubMed ID: 375825
[TBL] [Abstract][Full Text] [Related]
15. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
Deguchi K
Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021
[TBL] [Abstract][Full Text] [Related]
16. Cyclacillin, a semisynthetic aminoalicyclic penicillin. I. Antibacterial activity in vitro and in vivo compared with ampicillin and cephalexin.
Yurchenco JA; Hopper MW; Vince TD; Warren GH
Chemotherapy; 1970; 15(4):209-21. PubMed ID: 4394267
[No Abstract] [Full Text] [Related]
17. The role of penicillin acylase in the resistance of gram-negative bacteria to penicillins.
Cole M; Sutherland R
J Gen Microbiol; 1966 Mar; 42(3):345-56. PubMed ID: 5330787
[No Abstract] [Full Text] [Related]
18. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
Metz H
Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
[No Abstract] [Full Text] [Related]
19. Relationship between the chemotherapeutic effectiveness of ciclacillin and ampicillin and the time of their administration in experimental infections.
Arend P; Sous H; Poszich G; Mŭckter H
Arzneimittelforschung; 1975 Sep; 25(9):1382-5. PubMed ID: 1103895
[TBL] [Abstract][Full Text] [Related]
20. [Transmissible resistance toward polysynthetic penicillins].
Datta N
Antibiotiki; 1971 Jun; 16(6):523-5. PubMed ID: 5000147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
